Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
A global real world data analytics platform for the life sciences and healthcare industries

Additional services

In some cases a user may have complex queries that are best addressed in partnership with the SENSIGHT professional services team.

Our team are available to provide additional support and planning for your specific research needs. Fees will be costed on a project-specific basis. This includes:


Additional data for synthetic control arm trials

This could include the identification of missing data components or specific inclusion criteria such as mutation analyses, or a requirement to analyse the existing datasets in more complex ways.


Synthetic imaging control arms

These enable an expansion of synthetic control arms to integrate with image analysis pipelines for deeper analyses of disease progression and survival outcomes. This can include bespoke analysis such as RECIST.


Complex patient stratification

This may include supervised, unsupervised and semi-supervised techniques, along with more detailed causal analyses to support the identification of sub-phenotypes in a patient population.


Bespoke analysis of real world data

For complex and highly tailored analysis of product or class outcomes using AI or ML tools, or the development of data packages for regulatory or Health Technology Assessment (HTA) submissions.

Additional products

Additional products are available to SENSIGHT subscribers, for specific research projects. Fees are costed on a project-specific basis.

Biomarker search

Building knowledge around diagnosis, treatment and care pathways can reduce compound attritions.

Sensyne’s Biomarker Search service will, where possible, link genomic or panomic data to real world Electronic Patient Record (EPR) data to allow the association between SNPs, protein and disease expression to further increase confidence in target selection and facilitate the development of personalised medicines.

Outcomes based pricing data tracker

There is increasing appetite globally for outcomes-based or value-based pricing agreements. Tracking these real world outcomes however can be complex and resource intensive.

Sensyne Health can act as a trusted intermediary in the provision of data between supplier and payer using real world data obtained from the SENSIGHT platform.

Image quantification

Through the integration of large, analysed patient imaging cohorts into the SENSIGHT platform, users will be able to interrogate specific disease progression and outcomes using chest CT, MRI, RECIST and other markers.

Algorithm development and testing services

SENSIGHT’s development and testing services allow clinical developers to develop, test and train new algorithms on single or multiple data sets.

Leveraging large anonymised patient data sets and clinical expertise within the SENSIGHT platform, along with Sensyne’s imaging expertise, enables the rapid development of prototype AI applications to address research problems.